LNB autoritātes

AleppID: LNC10-000121330

ViafURL: http://viaf.org/viaf/61844635

DomID: 23696 Go to Dom link      Go to Dom xml data

IsniID: 0000000109079470

  • Leader
  • Kontrolnumurs (NA)
  • Pēdējās transakcijas datējums un laiks (NA)
  • Noteikta garuma datu elementi (NA)
  • Cits standarta identifikators (A)
  • Sistēmas kontrolnumurs (A)
  • Kataloģizācijas avots (NA)
  • Aprakstgalva—Personvārds (NA)
  • Avots, kurā dati ir atrasti (A)
  • Avots, kurā dati ir atrasti (A)
  • Elektroniskā atrašanās vieta un piekļuve (A)
  • Nedefinēts
  • 00000nz^^a2200000n^^4500
  • LNC10-000121330
  • 20081008115311.0
  • 081008nn|adnnnaabn||||||||||^a|aaa||||^^
  • 7 |A|0000000109079470|2|isni
  • |A|(VIAF)61844635
  • |A|LV-RiVB|B|lav
  • 1 |A|Jha, Prabhat,|D|1965-
  • |A|Improving health outcomes of the poor, 2002
  • |A|Kongresa bibliotēkas autorit. ierakstu datne
  • 40|U|http://viaf.org/viaf/61844635|Y|VIAF ID
  • 03|A|20081008.03INGUNAM
<ill-get-doc>
  <record xmlns="http://www.loc.gov/MARC21/slim/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
    <leader>^^^^^nz^^a^^^^^^^n^^4500</leader>
    <controlfield tag="001">LNC10-000121330</controlfield>
    <controlfield tag="005">20081008115311.0</controlfield>
    <controlfield tag="008">081008nn|adnnnaabn||||||||||^a|aaa||||^^</controlfield>
    <datafield tag="024" ind1="7" ind2=" ">
      <subfield code="a">0000000109079470</subfield>
      <subfield code="2">isni</subfield>
    </datafield>
    <datafield tag="035" ind1=" " ind2=" ">
      <subfield code="a">(VIAF)61844635</subfield>
    </datafield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">LV-RiVB</subfield>
      <subfield code="b">lav</subfield>
    </datafield>
    <datafield tag="100" ind1="1" ind2=" ">
      <subfield code="a">Jha, Prabhat,</subfield>
      <subfield code="d">1965-</subfield>
    </datafield>
    <datafield tag="670" ind1=" " ind2=" ">
      <subfield code="a">Improving health outcomes of the poor, 2002</subfield>
    </datafield>
    <datafield tag="670" ind1=" " ind2=" ">
      <subfield code="a">Kongresa bibliotēkas autorit. ierakstu datne</subfield>
    </datafield>
    <datafield tag="856" ind1="4" ind2="0">
      <subfield code="u">http://viaf.org/viaf/61844635</subfield>
      <subfield code="y">VIAF ID</subfield>
    </datafield>
    <datafield tag="915" ind1="0" ind2="3">
      <subfield code="a">20081008.03INGUNAM</subfield>
    </datafield>
  </record>
  <session-id>12UNVP19XJ9LEKSAAILUSE3CN44CGF39I9M54VN1VSMV83I3C9</session-id>
</ill-get-doc>        

Prabhat_Jha_(epidemiologist)

Iet uz wiki rakstu

  • Prabhat Jha OC&#91;1&#93;&#91;2&#93; (born February 12, 1965) is an Indian-Canadian epidemiologist currently working in the field of global health.
  • Jha is the founding director of the Centre for Global Health Research at St. Michael’s Hospital in Toronto, Ontario. His research focuses primarily on premature mortality resulting from HIV/AIDS, tobacco, alcohol, malaria, maternal, and child health, infectious and non-communicable diseases.&#91;3&#93;
  • Jha was born in Ranchi, India the state of Jharkhand. When he was six years old, his family moved to Winnipeg Canada where his father, Bidhu Jha, worked as a civil engineer and went on to become an NDP member of Manitoba’s legislative assembly.&#91;4&#93; Together, with his older brother and younger sister, he was raised by his mother.
  • Jha studied medicine at the University of Manitoba.&#91;1&#93; After earning his Doctor of Medicine degree, he attended the University of Oxford in England as a Rhodes Scholar&#91;1&#93; where he was mentored by statistician and epidemiologist Sir Richard Peto.&#91;5&#93; He successfully defended his PhD in epidemiology and public health in 1992.&#91;1&#93;
  • After graduation, Jha worked as a team leader at the World Bank, contributing to the development of the Second National HIV/AIDS Control Program in India.&#91;6&#93; He later worked as a senior scientist in health and poverty for the World Health Organization’s Commission on Macroeconomics and Health.
  • In 2002, he founded the Centre for Global Health Research at St. Michael's Hospital in Toronto, where he has directed a variety of large scale public health studies, most notably the Indian Million Death Study on premature mortality.&#91;7&#93; Jha’s research focuses on the causes of premature death in developing countries worldwide, and he has been recognized internationally for his work on smoking and tobacco related mortality.&#91;3&#93; He is also a member of the Disease Control Priorities Project.
  • Jha has been a Senior Fellow of Massey College at the University of Toronto, Canada since 2006 and in 2007 he became a professor of epidemiology at the Dalla Lana School of Public Health, University of Toronto.&#91;1&#93; In 2010 Jha was appointed the inaugural Endowed Chair in Disease Control at the Dalla Lana School.&#91;1&#93; In 2019 Jha was appointed University Professor at the University of Toronto, recognizing his outstanding scholarly achievement and contributions to the field of public health.&#91;8&#93; Jha has been an elected foreign member of the US National Academy of Medicine in the National Academies of Sciences, Engineering, and Medicine since 2016.&#91;9&#93; Jha has also been an elected fellow of the Royal Society of Canada since 2018.&#91;10&#93;
  • Jha has served as a health advisor to several governments including the Government of Canada on the Ministerial Advisory Committee on Tobacco Control, the Government of South Africa on its National Health Insurance Expert Committee, and the Government of India on the Advisory Committee for the National AIDS Control Organization.&#91;1&#93;
  • He was a founding senior editor of the scientific journal eLife&#91;6&#93; from 2011-2018 and is an International Advisory Board Member for The Lancet Global Health journal.&#91;1&#93;
  • Jha is the lead researcher behind the Action to Beat Coronavirus (Ab-C) study, where Unity Health, the University of Toronto and the Angus Reid Forum have teamed up to look at the prevalence of COVID-19 antibodies among 10,000 Canadians.&#91;11&#93;&#91;12&#93;